Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association

H Shimada, T Noie, M Ohashi, K Oba, Y Takahashi - Gastric cancer, 2014 - Springer
The aim of this review was to evaluate the clinical significance of serum tumor markers,
particularly CEA, CA19-9, and CA72-4, in patients with gastric cancer. A systematic literature …

[HTML][HTML] Evaluation and treatment of malignant ascites secondary to gastric cancer

H Maeda, M Kobayashi, J Sakamoto - World Journal of …, 2015 - ncbi.nlm.nih.gov
Malignant ascites affects approximately 10% of patients with gastric cancer (GC), and poses
significant difficulties for both patients and clinicians. In addition to the dismal general …

Techniques of staging laparoscopy and peritoneal fluid assessment in gastric cancer: a systematic review

K Rawicz-Pruszyński, M Erodotou, Z Pelc… - … Journal of Surgery, 2023 - journals.lww.com
Background: Staging laparoscopy for gastric cancer is recommended to assess the tumor's
locoregional extension and exclude peritoneal disease. As there is no consensus on …

Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis

XJ Chen, GM Chen, YC Wei, H Yu, XC Wang, ZK Zhao… - BMC cancer, 2021 - Springer
Background Gastric outlet obstruction (GOO) is a late complication of advanced gastric
cancer, and it is controversial how to select the therapeutic strategies: gastrojejunostomy …

Exosomal miR-181b-5p downregulation in ascites serves as a potential diagnostic biomarker for gastric cancer-associated malignant ascites

J Yun, SB Han, HJ Kim, S Go, WS Lee… - Journal of gastric …, 2019 - synapse.koreamed.org
Purpose Peritoneal carcinomatosis in gastric cancer (GC) patients results in extremely poor
prognosis. Malignant ascites samples are the most appropriate biological material to use to …

Body fluid analysis: clinical utility and applicability of published studies to guide interpretation of today's laboratory testing in serous fluids

DR Block, A Algeciras-Schimnich - Critical reviews in clinical …, 2013 - Taylor & Francis
Requests for testing various analytes in serous fluids (eg pleural, peritoneal, pericardial
effusions) are submitted daily to clinical laboratories. Testing of these fluids deviates from …

Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors?

M Hasbahceci, FU Malya, E Kunduz… - The Annals of The …, 2018 - publishing.rcseng.ac.uk
Introduction To evaluate the impact of serum and peritoneal levels of tumour markers on
peritoneal carcinomatosis and survival in gastric adenocarcinoma. Materials and methods …

The detection of gastric cancer cells in intraoperative peritoneal lavage using the reverse transcription–loop-mediated isothermal amplification method

A Yoneda, K Taniguchi, Y Torashima, S Susumu… - Journal of Surgical …, 2014 - Elsevier
Introduction To detect a small number of malignant cells, we used a highly sensitive
detection system that measures the expression levels of cytokeratin (CK) 19 messenger …

[HTML][HTML] Body fluid MMP-2 as a putative biomarker in metastatic breast cancer

S Noh, JJ Jung, M Jung, KH Kim… - Oncology …, 2012 - spandidos-publications.com
In the present study, we investigated the role of matrix metalloproteinase (MMP)-2 and-9 as
novel biomarkers in the body fluid of patients with metastatic breast cancer. We measured …

Clinical significance of carcinoembryonic antigen in peritoneal lavage from patients with gastric cancer

K Kanetaka, S Ito, S Susumu, A Yoneda, F Fujita… - Surgery, 2013 - Elsevier
Background Peritoneal carcinomatosis is the most common pattern of recurrence of gastric
cancer, and it is important to identify patients at high risk for recurrence. Although the …